| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.06 |